Lyudmila Rakita
Psychiatry · Brockton, MANPI 1700873999
Payments from drug & device makers
Across 537 payments — averaging $11.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sunovion Pharmaceuticals Inc.$773
- Lundbeck LLC$674
- Otsuka America Pharmaceutical, Inc.$665
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$554
- Vanda Pharmaceuticals Inc.$312
- plus $2K from 14 others
What the payments were for
- Food & beverage$5,97597%
- Education$1923%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 139 | $1,689 |
| Sunovion Pharmaceuticals Inc. | 71 | $773 |
| Lundbeck LLC | 127 | $674 |
| Otsuka America Pharmaceutical, Inc. | 39 | $665 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 46 | $554 |
| Vanda Pharmaceuticals Inc. | 27 | $312 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $274 |
| Eisai Inc. | 21 | $258 |
| Teva Pharmaceuticals USA, Inc. | 9 | $211 |
| Alkermes, Inc. | 13 | $181 |
| Merck | 7 | $142 |
| Neurocrine Biosciences, Inc. | 6 | $110 |
| Johnson & Johnson | 7 | $102 |
| Neos Therapeutics, LP | 5 | $69 |
| Bausch Health US, LLC | 2 | $46 |
| Jazz Pharmaceuticals Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Corium, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$115
- ABILIFY MAINTENA$115
- LATUDA$109
How this compares
$6,168 in reported general payments places this provider in the 90th percentile of 1,431 psychiatry providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 11 | $685 |
| Olanzapine | 11 | $554 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $396 |
| Lamotrigine | 17 | $284 |
| Clonazepam | 24 | $278 |
| Trazodone Hcl | 13 | $124 |
| Lorazepam | 15 | $45 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Brockton
- Lee CohenBoston$7M
- Dyanna DomiliciBoston$5.8M
- Arkadiy StolyarBelmont$3.3M
- Maurizio FavaBoston$2.8M
- Marc ShayAmesbury$1.7M
- Martha StarkNewton$1.6M
- Hadine JoffeBoston$1.5M
- Malini NairWinchester$1M
- Xiaoduo FanWorcester$950K
- Anthony RothschildWorcester$838K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.